In New York State, do more percutaneous coronary interventions mean fewer or more complex referrals to cardiac surgeons?

American Heart Hospital Journal

Volumn 6, Issue 1, 2008, Pages 30-36

  McLean, Thomas R ^a,b,c  

^a Eastern Kansas Health Care System   (United States)

^b Third Millennium Consultants LLC   (United States)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EMERGENCY SURGERY; HEALTH CARE DELIVERY; HEART EJECTION FRACTION; HUMAN; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REVIEW; SOCIAL STATUS; SURGEON; CANADA; EUROPE; FEMALE; HOSPITAL DEPARTMENT; MALE; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES; UTILIZATION REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CALIFORNIA; CANADA; EUROPE; FEMALE; HUMANS; MALE; NEW YORK; REFERRAL AND CONSULTATION; SURGERY DEPARTMENT, HOSPITAL;

EID: 41249102959     PISSN: 15419215     EISSN: 17517168     Source Type: Journal    
DOI: 10.1111/j.1751-7168.2008.07408.x     Document Type: Review

References (26)

1. McGrath LB, Laub GW, Graf D, et al. Hospital death on a cardiac service: negative influence of changing practice patterns. Ann Thorac Surg. 1990;49:410-412.
2. Hirshfeld JW, Wilensky RL. Drug-eluting stents are here-now what? Implications for clinical practice and health care costs. Cleve Clin J Med. 2004;71(10):825-828.
3. Klein LW. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease? J Am Coll Cardiol. 2006;47(1):22-26.
4. Guyton RA. Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease. Ann Thorac Surg. 2006;81:1949-1952.
5. Institute of Medicine. Rewarding Provider Performance: Aligning Incentives in Medicare. Washington, DC: NAS Press; 2007.
6. Peterson ED, DeLong ER, Jollis JG, et al. The effects of New York's bypass surgery provider profiling on access to care and patient outcomes in the elderly. J Am Coll Cardiol. 1998;32(4):993-999.
7. Jha AK, Epstein AM. The predictive accuracy of the New York State coronary artery bypass surgery report-card system. Health Aff (Millwood). 2006;25(3):844-855.
8. Heart Disease. New York State Department of Health Web site. http://www.health.state.ny.us/nysdoh/heart/heart_disease.htm. Accessed December 26, 2007.
9. Chassin MR. Achieving and sustaining improved quality: Lessons from New York State and cardiac surgery. Health Aff (Millwood). 2002;21(4):40-51.
10. Alter DA, Stukel TA, Newman A. Proliferation of cardiac technology in Canada: A challenge to the sustainability of Medicare. Circulation. 2006;113:380-387.
11. Target Setting Work Group Report, Cardiac Care Network of Ontario http://www.ccn.on.ca/pdfs%5Ctargset.pdf. Accessed August 10, 2007.
12. British Heart Foundation Statistics Web site. http://www.heartstats.org. Accessed December 26, 2007.
13. Wijns W. Evidence-based medicine and interventional cardiology. Cardio Update (Cordis). February 2004:3-4.
14. Kappetein AP, Dawkins KD, Mohr FW, et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Eur J Cardiothorac Surg. 2006;29(4):486-491.
15. Curfman GD, Morrissey S, Jarcho JA, et al. Drug-eluting coronary stents-promise and uncertainty. N Engl J Med. 2007;356(10):1059-1060.
16. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting verse stent implantation. N Engl J Med. 2005;352(21):2174-2183.
17. Tu HT, Ginsburg PB. Losing ground: Physician income, 1995-2003. Track Rep. 2006;(15):1-8.
18. Westphal SP. Concerns prompt some hospitals to pare use of drug-coated stents. Wall Street Journal. June 22, 2006:A1.
19. Hodgson JM, Bottner RK, Klein LW, et al. Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues. Catheter Cardiovasc Interv. 2004;62:1-17.
20. Hill R, Bagust A, Bakhai A, et al. Coronary artery stents: A rapid systematic review and economic evaluation. Health Technol Assess. 2004;8(35). http://www.hta.nhsweb.nhs.uk/execsumm/summ835.htm. Accessed December 26, 2007.
21. Hilborne LH, Leape LL, Bernstein SJ, et al. The appropriateness of use of percutaneous transluminal angioplasty in New York State. JAMA. 1993;269(6):761-765.
22. Leape LL, Hilborne LH, Park RE, et al. The appropriateness of coronary artery bypass graft surgery in New York State. JAMA. 1993;269(6):753-760.
23. Gandjour A, Neumann I, Lauterbach KW. Appropriateness of invasive cardiovascular interventions in German hospitals (2000-2001): An evaluation using RAND appropriateness criteria. Eur J Cardiothorac Surg. 2003;24(4):571-577.
24. Steinbrook R. Public report cards-cardiac surgery and beyond. N Engl J Med. 2006;355:1847-1849.
25. Richard SA, Rawal S, Martin DK. An ethical framework for cardiac report cards: A qualitative study. BMC Med Ethics. 2005;6:E3.
26. Guru V, Fremes SE, Naylor CD, et al. Public versus private institutional performance reporting: What is mandatory for quality improvement? Am Heart J. 2006;152(3):573-578.